Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025
The Best U.S. Value Stocks by Quant: AGIO, DLX, PPC
TD Cowen Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating
Express News | Cantor Fitzgerald Reiterates Overweight on Agios Pharmaceuticalsto Overweight
The European Commission Has Adopted A Positive Decision For The Designation Of Agios Pharmaceuticals' Mitapivat As An Orphan Medicinal Product For Sickle Cell Disease
European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios' Mitapivat in Sickle Cell Disease
